Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2025-12-26 @ 11:13 PM
Study NCT ID:
NCT06025812
Status:
UNKNOWN
Last Update Posted:
2023-09-06
First Post:
2023-08-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Clinical Study of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)
Sponsor:
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-20
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-05-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-30
First Submit QC Date:
None
Study First Post Date:
2023-09-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-05
Last Update Post Date:
2023-09-06
Last Update Post Date Type:
ACTUAL